Afya/$AFYA

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX

About Afya

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

Ticker

$AFYA
Primary listing

Industry

Diversified Consumer Services

Headquarters

Nova Lima, Brazil

Employees

-

ISIN

KYG011251066

Afya Metrics

BasicAdvanced
$1.6B
12.59
$1.39
0.60
$0.23
1.33%

What the Analysts think about Afya

Analyst ratings (Buy, Hold, Sell) for Afya stock.

Bulls say / Bears say

Afya reported strong financial results for Q4 and full-year 2024, with net revenue up 16.3% year-over-year to R$849.0 million and adjusted EBITDA increasing by 26.7% to R$366.0 million, indicating robust operational performance. (stocktitan.net)
The company announced its first dividend distribution of R$129.8 million, representing 20% of its 2024 net income, demonstrating a commitment to returning value to shareholders. (stocktitan.net)
Afya secured a R$500 million sustainability-linked loan from the International Finance Corporation to support its expansion program, highlighting confidence in its growth strategy. (stocktitan.net)
JPMorgan Chase & Co. lowered its price target for Afya from $25.00 to $20.50, maintaining a 'neutral' rating, suggesting tempered expectations for the stock's performance. (americanbankingnews.com)
Morgan Stanley downgraded Afya from 'equal weight' to 'underweight' and reduced the price target from $19.00 to $17.00, indicating concerns about the company's valuation. (defenseworld.net)
Afya's stock experienced a gap down in February 2025, opening at $15.96 after closing at $16.84, reflecting potential volatility and investor uncertainty. (americanbankingnews.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jul 2025.

Afya Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Afya Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $AFYA

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs